Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS
- PMID: 12447931
- DOI: 10.1002/ana.10374
Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS
Abstract
The pathogenesis of cell death in amyotrophic lateral sclerosis (ALS) may involve glutamate-mediated excitotoxicity, oxidative damage, and apoptosis. We used a transgenic mouse model of ALS to determine the effect of inhibition of cyclooxygenase-2 in treating the disease. Cyclooxygenase-2, present in spinal neurons and astrocytes, catalyzes the synthesis of prostaglandin E2. Prostaglandin E2 stimulates glutamate release from astrocytes, whereas cyclooxygenase-2 also plays a key role in the production of proinflammatory cytokines, reactive oxygen species, and free radicals. Treatment with a selective cyclooxygenase-2 inhibitor, celecoxib, markedly inhibited production of prostaglandin E2 in the spinal cords of ALS mice. Celecoxib treatment significantly delayed the onset of weakness and weight loss and prolonged survival by 25%. Spinal cords of treated ALS mice showed significant preservation of spinal neurons and diminished astrogliosis and microglial activation. Our results suggest that cyclooxygenase-2 inhibition may benefit ALS patients.
Similar articles
-
Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis.Ann Neurol. 2000 Nov;48(5):792-5. Ann Neurol. 2000. PMID: 11079544
-
A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis.FASEB J. 2003 Apr;17(6):725-7. doi: 10.1096/fj.02-0876fje. Epub 2003 Feb 5. FASEB J. 2003. PMID: 12586733
-
Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis.Ann Neurol. 2001 Feb;49(2):176-85. Ann Neurol. 2001. PMID: 11220737
-
COX-2 and ALS.Amyotroph Lateral Scler Other Motor Neuron Disord. 2001 Sep;2(3):121-2. doi: 10.1080/146608201753275562. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001. PMID: 11771766 Review. No abstract available.
-
Update on the pathological roles of prostaglandin E2 in neurodegeneration in amyotrophic lateral sclerosis.Transl Neurodegener. 2023 Jun 19;12(1):32. doi: 10.1186/s40035-023-00366-w. Transl Neurodegener. 2023. PMID: 37337289 Free PMC article. Review.
Cited by
-
Reactive astrocytes as therapeutic targets for CNS disorders.Neurotherapeutics. 2010 Oct;7(4):494-506. doi: 10.1016/j.nurt.2010.07.003. Neurotherapeutics. 2010. PMID: 20880511 Free PMC article. Review.
-
Neuronal cyclooxygenase-2 activity and prostaglandins PGE2, PGD2, and PGF2 alpha exacerbate hypoxic neuronal injury in neuron-enriched primary culture.Neurochem Res. 2008 Mar;33(3):490-9. doi: 10.1007/s11064-007-9462-2. Epub 2007 Aug 31. Neurochem Res. 2008. PMID: 17763946
-
Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis.Cell Mol Life Sci. 2014 Mar;71(6):999-1015. doi: 10.1007/s00018-013-1480-4. Epub 2013 Oct 8. Cell Mol Life Sci. 2014. PMID: 24100629 Free PMC article. Review.
-
Sex-dependent effects of chromogranin B P413L allelic variant as disease modifier in amyotrophic lateral sclerosis.Hum Mol Genet. 2016 Nov 1;25(21):4771-4786. doi: 10.1093/hmg/ddw304. Hum Mol Genet. 2016. PMID: 28175304 Free PMC article.
-
Endoplasmic Reticulum Stress Interacts With Inflammation in Human Diseases.J Cell Physiol. 2016 Feb;231(2):288-94. doi: 10.1002/jcp.25098. J Cell Physiol. 2016. PMID: 26201832 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
